An Improvement Project Around Staffs' Influenza Vaccine Uptake

Influenza Vaccination Clinical Trial

Official title:

An Improvement Project to Evaluate the Effectiveness of Different Reminders Designed to Increase the University Hospitals Birmingham NHS Foundation Trust's Staff Uptake of the Seasonal Influenza Vaccine

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03637036
• Other study ID #: RRK6479
• Status: Completed
• Phase: N/A
• Start date: September 24, 2018
• Est. completion date: January 4, 2019

Study information

• Verified date: January 2019
• Source: University of Warwick
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

To reach seasonal vaccination against influenza targets, University Hospitals Birmingham (UHB) already invites staff to take up the vaccination, and every November reminds staff that have not yet vaccinated to do so. The current protocol describes a randomized controlled trial (RCT) in which staff will be sent different reminders, and the investigators will compare the proportion of staff that go on to vaccinate after receiving each reminder.

Description:

Seasonal vaccination against influenza is recommended for NHS staff. , To increase vaccination rates, NHS England put forth a Commissioning for Quality and Innovation goal for the 2018/2019 season of 75%. University Hospitals Birmingham NHS Foundation Trust (UHB) wants its vaccination rate to surpass this target. Since staff get infected outside of the hospital and from patients staff vaccination does not provide significant 'herd immunity'

To reach past targets, every September UHB already invites staff to take up the vaccination, and regularly reminds staff that have not yet vaccinated to do so. The current protocol describes a randomized controlled trial (RCT) in which staff will be sent a different letter when first invited to receive vaccination, and we will compare the proportion of staff that go on to vaccinate after receiving each type of letter..

To conduct the RCT the research team will design four letter styles. One factor will emphasize an authority figure inviting staff to vaccinate (the Chief Executive, who is also a doctor). The other factor will emphasize a competitive social norm describing vaccination rates in peer hospitals, including Addenbrooke's, Cambridge University Hospitals (which has exemplary rates) see appendix A and across American hospitals (which also have high rates). Letters will be sent to staff in the first week in October by UHB's communications team and they will be disseminated in a randomized fashion.

The UoW's role in this study is to advise the study's design and write-up the project for publication. UHB will approve the reminders, send the reminders, retrieve the data, and analyse the data. No individual-level data will be transferred across organizations. All individual-level data will be managed by authorized UHB employees, e.g., a UHB statistician will randomize staff to receive different reminders and analyze the data, and UHB's communication team to disseminate the reminders.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 8438
• Est. completion date: January 4, 2019
• Est. primary completion date: January 4, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• All UHB staff eligible for the seasonal influenza vaccination are eligible for this study. (no patients are included)

Related Conditions & MeSH terms

• Influenza Vaccination
• Influenza, Human

Intervention

Other:
• Communication intervention
The intervention is a communication inviting staff to take up the influenza vaccination. Different versions of the communication are created, and the investigators will compare uptake rates between staff that received different letters.

Locations

Country	Name	City	State
United Kingdom	University Hospitals Birmingham NHS Foundation Trust (UHB)	Birmingham

Sponsors (2)

Lead Sponsor	Collaborator
University of Warwick	University Hospital Birmingham

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Group number	This data describes what communication participants received	3 months
Other	Worksite	This data describes what location within the organization participants work	3 months
Other	Job Role	This data describes participants' job roles	3 months
Other	Gender	This data describes participants' gender	3 months
Primary	Vaccination uptake	Whether participants vaccinated (Yes, No)	3 months
Secondary	Vaccination uptake date	The date participants received vaccination (DD-MM-YYYY or blank if not vaccinated)	3 months
Secondary	Vaccination uptake reflusal	Whether participants formally indicated refusal to vaccinate (Yes, No)	3 months
Secondary	Vaccination uptake alternative location	Whether participants formally indicated being vaccinated at another location (Yes, No)	3